Literature DB >> 11264964

Iscador Qu for chronic hepatitis C: an exploratory study.

K J Tusenius1, J M Spoek, C W Kramers.   

Abstract

Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11264964     DOI： 10.1054/ctim.2000.0408

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN： 0965-2299            Impact factor:   2.446


  4 in total

1.  Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2.

Authors:  Pushpa Hegde; Mohan S Maddur; Alain Friboulet; Jagadeesh Bayry; Srini V Kaveri
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

2.  Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells.

Authors:  Sidra Rehman; Usman A Ashfaq; Sana Riaz; Tariq Javed; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-05-12       Impact factor: 4.099

3.  Anthroposophic medicine: an integrative medical system originating in europe.

Authors:  Gunver S Kienle; Hans-Ulrich Albonico; Erik Baars; Harald J Hamre; Peter Zimmermann; Helmut Kiene
Journal:  Glob Adv Health Med       Date:  2013-11

Review 4.  Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action.

Authors:  Anna Szurpnicka; Anna Kowalczuk; Arkadiusz Szterk
Journal:  Arch Pharm Res       Date:  2020-07-03       Impact factor: 4.946
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.